Steven Cohen’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,600
Closed -$136K – 3894
2026
Q2
$136K Buy
+7,600
New +$118K ﹤0.01% 3637

Other funds holding AMLX

Steven Cohen's AMLX Position: Q3 2026 in Review

Steven Cohen opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 388,699 shares worth $11.3M. The stake represents 0.01% of the portfolio and ranks #1278 among its holdings. This is a return to the name: Steven Cohen previously reported a position in AMLX as recently as Q1 2026.

Steven Cohen first reported a position in AMLX in Q2 2022 and has held it in 15 quarters since. The position peaked at $78.6M in Q4 2022. 228 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Steven Cohen held 388,699 shares of Amylyx Pharmaceuticals worth $11.3M as of Q3 2026.
  • Amylyx Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Amylyx Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1278 holding.
  • Steven Cohen first reported a position in Amylyx Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • Steven Cohen's Amylyx Pharmaceuticals position peaked at $78.6M in Q4 2022.
  • 228 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.